Hypercalcemia induced by tamoxifen.
A case of hypercalcemia induced by tamoxifen in a patient with breast carcinoma metastatic to the bones is presented. The induction of the hypercalcemia may be secondary to the weak initial estrogenic effects of tamoxifen. Patients who are treated with tamoxifen and other antiestrogens should be monitored carefully for evidence of hypercalcemia.
D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D013629:Tamoxifen